Eye care goliath Bausch & Lomb may be looking to go public this year, a move that would signal renewed confidence in the company following a bit of a rough patch.
Bausch was taken private in 2007 by Warburg Pincus for $4.5 billion after accounting discrepancies forced the company to restate its earnings and contaminated contact disinfectant solution resulted in a high-profile recall.